IL-1 RAcP/IL-1 R3 Antibody (89412R) [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # FAB676RY
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 89412R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf21-derived recombinant human IL-1RAcP/IL-1 R3
Ser21-Glu359
Accession # Q9NPH3
Ser21-Glu359
Accession # Q9NPH3
Specificity
Detects human IL-1RAcP/IL-1R3 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for IL-1 RAcP/IL-1 R3 Antibody (89412R) [DyLight 680]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-1 RAcP/IL-1 R3
Long Name
Interleukin 1 Receptor Accessory Protein
Alternate Names
IL-1 R3, IL-1RAcP, IL1RAcP, IL1RAP
Gene Symbol
IL1RAP
Additional IL-1 RAcP/IL-1 R3 Products
Product Documents for IL-1 RAcP/IL-1 R3 Antibody (89412R) [DyLight 680]
Product Specific Notices for IL-1 RAcP/IL-1 R3 Antibody (89412R) [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...